Pharmaceutical Marketing Tactics Matched to Brand Objectives
Pharmaceutical marketing tactics organized by the job they do: awareness, education, trial, access, adherence, and advocacy, with HCP and DTC examples.
The short answer
Pharmaceutical marketing tactics are the specific activities a brand uses to reach HCPs and patients: field sales, email, endemic and programmatic media, point of care, CTV, search, social, speaker and education programs, access support, and adherence programs. The useful way to choose them is by job: each tactic should remove a specific barrier, such as low awareness, unclear patient selection, access delays, or drop-off after the first fill.
Tactic lists are easy to find. The harder question is which tactic does which job. This catalog groups common pharma tactics by objective so you can match them to the barriers in your plan.
Awareness: "I know it exists"
| Tactic | Audience | Notes |
|---|---|---|
| NPI-matched programmatic display and video | HCP | Scale on a defined list |
| Endemic medical site sponsorships | HCP | Clinical context, premium cost |
| Conference presence | HCP | Concentrated specialists |
| TV and CTV | Patient | Broad reach; required risk presentation |
| Paid social | Both | Platform health policies apply |
| Disease awareness campaigns | Patient | Unbranded; useful pre-launch |
Education: "I understand who it is for"
- HCP email with clinical content. See HCP email marketing.
- Medical education programs and webinars.
- Field discussions.
- Patient education content on brand and condition sites.
- Search ads that answer questions. See pharmaceutical PPC.
Trial: "I will try it"
- Point-of-care and EHR messages near prescribing. See point-of-care marketing.
- Samples and starter programs, where allowed.
- Patient-type case content for HCPs.
- DTC calls to action that prompt a conversation with a doctor.
Access: "My patient can get it"
- Access and reimbursement support content for practice staff.
- Field reimbursement managers.
- Copay and savings programs. See copay and savings messaging.
- Pull-through messages after formulary wins. See market access pull-through.
Adherence: "I stay on it"
- Patient support programs and nurse educators.
- Refill reminders through opted-in channels.
- Content on managing side effects.
- See adherence and refill marketing.
Advocacy: "I recommend it"
- Peer education programs within compliance rules.
- New data communications to adopters.
- See HCP advocacy measurement.
Choosing between tactics
Ask four questions for each candidate:
- Does it reach the audience that has the barrier?
- Can it carry the depth of message needed?
- What does a reached HCP or patient cost compared with alternatives?
- Can we measure whether it removed the barrier?
A tactic that fails the fourth question can still be worth running, but treat its budget as a bet and keep it small until you can measure it.
Tactics change with the lifecycle
Launch brands lean on awareness and education. Mature brands shift weight to access, adherence, and defending share. Brands approaching loss of exclusivity often cut broad media and protect loyal patients. See pharma marketing across the product lifecycle.
Common mistakes
- Choosing tactics because a competitor uses them.
- Spreading budget thinly across every tactic.
- Using awareness tactics to solve an access problem.
- No measurement plan for new tactics.
Practical takeaway
Sort last year's tactics into the six jobs above and add the spend for each. If most money sits in awareness while your main barrier is access or adherence, the tactic mix is out of step with the plan.
Frequently asked questions
What are the most common pharma marketing tactics?
Field sales, HCP email, endemic medical sites, NPI-matched programmatic, point of care, conferences, DTC TV and CTV, paid search, social, and patient support programs.
How do you choose pharma marketing tactics?
Start from the barrier you need to remove and the audience that has it, then pick tactics that can reach that audience with the right depth of message, and that you can measure.
Are tactics different for HCPs and patients?
Yes. Many channels overlap, but content, rules, targeting, and measurement differ. Some tactics, such as samples and speaker programs, are HCP only.
Sources
- FDA, Prescription Drug Advertising
- Google Ads policy, Healthcare and medicines
- PhRMA, Code on Interactions With Health Care Professionals
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.